Attenuated up-regulation of vitamin D-dependent calcium-binding proteins by 22-oxa-1,25-dihydroxyvitamin D3 in uremic rats: A possible mechanism for less-calcemic action

Nephrology

Volumn 4, Issue 5-6, 1998, Pages 391-395

  Ichikawa, Fumihiko ^a   Hirata, Michinori ^a   Endo, Koichi ^a   Katsumata, Kyoko ^a   Ohkawa, Hiroyuki ^a   Kubodera, Noboru ^e   Fukagawa, Masafumi ^b,d   Kurokawa, Kiyoshi ^c  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO TEISHIN HOSPITAL   (Japan)

^e NONE

Author keywords

22 Oxa 1,25D3; Calcium binding protein; Chronic renal failure; Parathyroid hormone; Secondary hyper parathyroidism; Vitamin D

Indexed keywords

22 OXACALCITRIOL; CALCIUM BINDING PROTEIN; VITAMIN D;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM TRANSPORT; CHRONIC KIDNEY FAILURE; DIALYSIS; DRUG EFFECT; INTESTINE ABSORPTION; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 0032453729     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1998.tb00377.x     Document Type: Article

References (31)

1. 1. Malluche H, Faugere MC. Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 1990; 38: 193-211.
2. 2. Coburn JW, Llach F, Renal osteodystrophy. In: Narins RG (ed.) Clinical Disorders of Fluid and Electrolyte Metabolism 5th edn. McGraw Hill Book Co., New York, 1994; 1299-1377.
3. 3. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J. Clin. Invest. 1984; 74: 2136-43.
4. 4. Abe J, Morikawa M, Miyamoto K et al. Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia. FEBS Lett. 1987; 226: 58-62.
5. 5. Abe J, Takita Y, Nakano T, Miyaura C, Suda T, Nishii Y. A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology 1989; 124: 2645-7.
6. 6. Brown AJ, Ritter CR, Finch JL et al. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J. Clin. Invest. 1989; 84: 728-32.
7. 7. Fukagawa M, Kaname S, Igarashi T, Ogata E, Kurokawa K. Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int. 1991; 39: 874-51.
8. 8. Kubrusly M, Gagne ER, Urena P et al. Effect of 22-oxa-calcitriol on calcium metabolism in rats with severe secondary hyperparathyroidism. Kidney Int. 1993; 44: 551-6.
9. 9. Dusso AS, Negrea L, Gunawardhana S et al. On the mechanisms for the selective action of vitamin D analogs. Endocrinology 1991; 128: 1687-1692.
10. 10. Kumar R. Vitamin D metabolism and mechanism of calcium transport. J. Am. Soc. Nephrol. 1990; 1: 30-42.
11. 11. Brown, AJ, Finch, J, Grieff, M et al. The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine. Endocrinology 1993; 133: 1158-1164.
12. 12. Spencer R, Charman M, Wilson PW, Lawson EM. The relationship between vitamin D-stimulated calcium transport and intestinal calcium-binding protein in the chicken. Biochem. J. 1978; 170: 93-101.
13. 13. Chomczynski P, Sacchi N. Acid guanidium thiocyanate-phenolchloroform methods. Anal Biochem. 1987; 162: 156-9.
14. 14. Heinrich G, Kronenberg HM, Potts JT, Habener JF. Gene encoding parathyroid hormone. Nucleotide sequence of the rat gene and deduced amino acid sequence of rat preproparathyroid hormone. J. Biol. Chem. 1984; 259: 3320-9.
15. 15. Fukagawa M, Fukuda N, Yi H, Kurokawa K. Resistance of parathyroid cell to calcitriol as a cause of parathyroid hyperfunction in chronic renal failure. Nephrol. Dial. Transplant 1995; 10: 316-9.
16. 3 in the parathyroid glands of patients with renal failure. N. Engl. J. Med. 1987; 316: 1573-7.
17. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J. Clin. Inves.t 1993; 92: 1436-43.
18. 18. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard, DJ. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N. Engl. J. Med. 1989; 321: 274-9.
19. 19. Fukagawa, M, Okazaki R, Takano, K et al. Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long term dialysis. N. Engl. J. Med. 1990; 323: 421-2.
20. 3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism. Nephron 1990; 57: 23-8.
21. 3 and 22-oxacalcitriol on phosphate and calcium metabolism. Kidney Int. 1993; 43: 561-6.
22. 3, in rats. J. Biochem. 1994; 115: 373-80.
23. 3. J. Nutr. Sci. Vitaminol. 1989; 35: 529-33.
24. 3. J. Bone Mineral Res. 1992; 7: 835-9.
25. 25. Corradino RA, Wasserman RH. Vitamin D3: induction of calcium-binding protein in embryonic chick intestine in vitro. Science 1971; 172: 731-3.
26. 26. Wasserman RH, Corradino RA, Feher JJ, Arbrecht HJ. Temporal patterns of response of the intestinal calcium absorptive system and related parameters to 1,25-dihydroxycholecalciferol. In: Norman AW et al. (eds) Vitamin D: Biochemical, Chemical, and Clinical Aspects Related to Calcium Metabolism. de Gruyter, New York, 1977; 331-340.
27. 3 in the intestinal calcium transport mechanism. Endocrinology 1982; 111: 1546-51.
28. 28. Dupret JM, Brun P, Perret C, Lomri N, Thomasset M, Cuisinier-Gleizes P. Transcriptional and post-transcriptional regulation of vitamin D-dependent calcium-binding protein gene expression in the rat duodenum by 1,25-dihydroxycholecalciferol. J. Biol. Chem 1987; 262: 16553-7.
29. 29. Hemmingsen C, Staun M, Lewin E, Nielsen PK, Olgaard K. Effect of vitamin D metabolites and analogs on renal and intestinal calbindin-D in the rat. Calcif. Tissue Int. 1996; 59: 371-6.
30. 30. Kurokawa K, Akizawa T, Suzuki M, Akiba T, Ogata E, Slatopolsky E. Effect of 22-oxacalcitriol on hyperparathyroidism of chronic dialysis patients: results of a preliminary study. Nephrol. Dial. Tranplant 1996; 11: 121-4.
31. 3 in parathyroid cells, is a potent inhibitor of parathyroid hormone secretion (abstract). Tenth Workshop on Vitamin D, Strasbourg, 1977; 246.